Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Plasma methylmalonic acid concentration in folic acid–supplemented depressed patients with low or marginal vitamin B-12: a randomized trial

Carter, Ben, Zenasni, Zohra, Moat, Stuart J., Hudson, Peter R., Russell, Ian T. and McCaddon, Andrew 2021. Plasma methylmalonic acid concentration in folic acid–supplemented depressed patients with low or marginal vitamin B-12: a randomized trial. The Journal of Nutrition 151 (12) , pp. 3738-3745. 10.1093/jn/nxab280

[thumbnail of 1-s2.0-S0022316622004357-main.pdf] PDF - Published Version
Available under License Creative Commons Attribution.

Download (543kB)
License URL: http://www.elsevier.com/open-access/userlicense/1.0/
License Start date: 19 January 2023

Abstract

Background Individuals with low serum vitamin B-12 and high serum folate have higher plasma concentrations of methylmalonic acid (MMA). Whether folic acid (FA) causes an increase in MMA is not known. Objectives We aimed to determine the impact of FA supplementation on plasma MMA concentration in people with low or marginal serum vitamin B-12. Methods We conducted a multicenter double-blind placebo-controlled randomized trial of oral FA (5 mg/d for 12 wk) in middle-aged patients treated with antidepressant medication participating in the FoLATED (Folate Augmentation of Treatment—Evaluation for Depression) trial. Participants defined as having “low” serum vitamin B-12 (vitamin B-12 ≥150 and <220 ng/L) or “marginal” serum vitamin B-12 (vitamin B-12 ≥ 220 and <280 ng/L) were included. The primary outcome of this substudy was MMA at week 12. A mixed-effects linear regression was fitted and reported using the adjusted mean difference (aMD). Results A total of 177 participants were included (85 randomly assigned to placebo and 92 to FA); the mean ± SD age was 46.2 ± 11.8 y, and 112 (63.3%) were female. The MMA analysis included 135 participants and the aMD was −0.01 (95% CI: −0.06, 0.04; P = 0.71). Serum folate was measured on 166 participants and increased in the supplementation group; the aMD was 21.6 μg/L (95% CI: 8.13, 25.02 μg/L; P < 0.001). A total of 117 participants were assessed for RBC folate, which also increased in the supplementation group; the aMD was 461 μg/L (95% CI: 387, 535 μg/L; P < 0.001). Conclusions Supplementation of FA leads to an increase of serum and RBC folate, but does not change plasma MMA concentration in individuals with serum vitamin B-12 between 150 and 280 ng/L. We cannot exclude effects in older people or those with serum vitamin B-12 <150 ng/L. Previously reported associations may arise from effects of impaired vitamin B-12 status on folate metabolism. This trial was registered at www.isrctn.com as ISRCTN37558856.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Additional Information: License information from Publisher: LICENSE 1: URL: http://www.elsevier.com/open-access/userlicense/1.0/, Start Date: 2023-01-19
Publisher: Oxford University Press
ISSN: 0022-3166
Date of First Compliant Deposit: 24 January 2023
Date of Acceptance: 2 August 2021
Last Modified: 03 May 2023 07:21
URI: https://orca.cardiff.ac.uk/id/eprint/156199

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics